Rezvoglar KwikPen (Insulin Glargine-aglr)
REZVOGLAR(TM) is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use. REZVOGLAR is not recommended for the treatment of…
REZVOGLAR(TM) is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use. REZVOGLAR is not recommended for the treatment of…
STRATTERA is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). (1.1) 1.1 Attention-Deficit/Hyperactivity…
SYMBYAX is indicated for the treatment of: Acute depressive episodes in Bipolar I Disorder [see Clinical Studies (14.1)]. Treatment resistant depression (Major Depressive Disorder in…
TALTZ is a humanized interleukin-17A antagonist indicated for the treatment of: patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic…
TAUVID is indicated for use with positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2024. All Rights Reserved.